CN) (CNSX:LXX) (LXRP) DehydraTECH™ which represents a breakthrough in cannabinoid drug delivery. Lexaria’s DehydraTECH™ is technology that promotes a molecular association between cannabinoids and certain fatty acid compounds that are known to have palatability and bio-absorption … Read More
The post Lexaria Expands into Transdermal, Grows Licensing Revenue — CFN Media appeared first on Dagga Magazine.